ams-OSRAM AG Unsponsored ADR (OTCMKTS:AMSSY – Get Free Report) saw an uptick in trading volume on Thursday . 3,762 shares were traded during trading, an increase of 324% from the previous session’s volume of 887 shares.The stock last traded at $5.37 and had previously closed at $5.4020.
Analyst Upgrades and Downgrades
Several research analysts have recently commented on the company. Zacks Research upgraded ams-OSRAM from a “strong sell” rating to a “hold” rating in a report on Wednesday, February 11th. Deutsche Bank Aktiengesellschaft downgraded ams-OSRAM to a “hold” rating in a research report on Wednesday, February 11th. Three research analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock currently has an average rating of “Reduce”.
Get Our Latest Research Report on ams-OSRAM
ams-OSRAM Price Performance
ams-OSRAM (OTCMKTS:AMSSY – Get Free Report) last announced its quarterly earnings results on Tuesday, February 10th. The company reported $0.20 EPS for the quarter, topping analysts’ consensus estimates of $0.04 by $0.16. The company had revenue of $1.02 billion during the quarter, compared to analyst estimates of $870.83 million. ams-OSRAM had a positive return on equity of 6.11% and a negative net margin of 3.76%. On average, analysts anticipate that ams-OSRAM AG Unsponsored ADR will post 0.67 earnings per share for the current fiscal year.
About ams-OSRAM
ams-OSRAM AG is a global technology company specializing in optical solutions, combining the sensor expertise of ams with the lighting heritage of OSRAM. The company develops and manufactures a broad range of high-performance products, including light-emitting diodes (LEDs), laser diode and infrared (IR) emitters, optical sensors, and sensor interfaces. These components are used across a variety of applications to enable advanced illumination, sensing, and imaging capabilities.
The company’s product portfolio serves diverse end markets such as consumer electronics, automotive, industrial, and medical.
Featured Stories
Receive News & Ratings for ams-OSRAM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ams-OSRAM and related companies with MarketBeat.com's FREE daily email newsletter.
